DVAX   $11.42  -0.31% Market Closed

Dynavax Technologies Corp
Last Events:

2023-03-29 Trend pattern changed from нисходящий треугольник to сужающийся канал.

2023-03-29 Signal in Stochastic changed from bearish recovery to bearish reversal. The stochastic indicator is in the upper part of the neutral territory and left the overbought territory. These factors indicate that perhaps the upside trend is coming to an end price will probably head south Last signal: exit from the overbought zone.

2023-03-29 Signal in MACD changed from bearish recovery to bullish weakening. Oscillator MACD is in the positive territory it's higher than the signal line and falls. These factors mean that the growing trend persists, but the growth rate is declining. Last signal: signal line crossed the middle level.

2023-03-29 Signal in RSI changed from bearish recovery to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.

2023-03-29 Signal in EMA50 changed from bearish reversal to bullish reversal. 2023-01-23 the price crossed up the moving average line and getting closer to the MA, which means that the short-term upside trend weakens.

2023-03-29 Signal in EMA20 changed from bearish reversal to bullish reversal. 2023-01-11 the price crossed up the moving average line and getting closer to the MA, which means that the upside trend weakens.

2023-03-29 Trend pattern changed from сужающийся канал to нисходящий треугольник.

2023-03-29 Signal in Stochastic changed from bearish reversal to bearish recovery. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: main and signal line crossing.


Current temperature: 1.54
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 9.72
Target: 23.20
High with 50% probability: 16.57
Analyst Recommendations:
Number of estimates 5
Target Price Mean 23.20
Mean unverified/preliminary 23.20 / 23.20
Target Price Low / High 20.00 / 28.00
Median / STD DEV 22.00 / 3.27
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total - - ActivelyBuy
rsi ActivelyBuy Sell ActivelyBuy
macd ActivelyBuy Buy ActivelyBuy
stoch Sell - -
ma20 - - -
ma50 ActivelyBuy - -
ma100 - ActivelyBuy -
Candlestick PatternJan. 27, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US2681582019
ceo Mr. Ryan Spencer
Website https://www.dynavax.com
Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.